Cladribina compresse: nuovi dati sulla sua efficacia
Darmstadt, Germania, 27 settembre 2016 – Merck, azienda leader in ambito scientifico e tecnologico, nel corso di due...
Il CHMP conferma il proprio parere negativo iniziale in merito alla richiesta di autorizzazione all’immissione in commercio per Cladribina compresse
· Merck Serono ribadisce la...
Presentati nel corso del 62° Meeting Annuale dell’American Academy of Neurology nuovi dati a sostegno di Cladribina compresse come possibile nuova opzione terapeutica
Toronto, Canada...
Questo sito usa i cookies per migliorare la tua navigabilità. Sei in accordo col loro utilizzo, ma puoi scegliere di non usarli.Accetto
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
